Gavekal Capital: European Biotech: Continued Outperformance

Friday, June 20, 2014

European Biotech: Continued Outperformance

Members of the MSCI Europe Biotechnology sub-industry continue to outperform:

image
image
image

Valuations are not extremely compelling:
image

Relative to history, however, valuations have moderated for some members of the group:
image